These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 27809860

  • 1. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction.
    Han WX, Chen ZM, Wei ZJ, Xu AM.
    World J Surg Oncol; 2016 Nov 03; 14(1):279. PubMed ID: 27809860
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 3. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.
    Zhang L, Su Y, Chen Z, Wei Z, Han W, Xu A.
    Medicine (Baltimore); 2017 Jul 25; 96(30):e7647. PubMed ID: 28746229
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M, Yamashita H, Watanabe T, Seto Y.
    World J Surg; 2018 Jan 25; 42(1):185-194. PubMed ID: 28741195
    [Abstract] [Full Text] [Related]

  • 5. [Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].
    Jin P, Ma G, Liu Y, Ke B, Liu HM, Liang H, Zhang RP.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan 25; 27(1):54-62. PubMed ID: 38262901
    [Abstract] [Full Text] [Related]

  • 6. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
    Reim D, Gertler R, Novotny A, Becker K, zum Büschenfelde CM, Ebert M, Dobritz M, Langer R, Hoefler H, Friess H, Schumacher C.
    Ann Surg Oncol; 2012 Jul 25; 19(7):2108-18. PubMed ID: 22130620
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.
    Chen Y, Jin M, Shao Y, Xu G.
    Dis Markers; 2019 Jul 25; 2019():4659048. PubMed ID: 31781301
    [Abstract] [Full Text] [Related]

  • 8. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction.
    Xiao JW, Liu ZL, Ye PC, Luo YJ, Fu ZM, Zou Q, Wei SJ.
    World J Gastroenterol; 2015 Sep 14; 21(34):9999-10007. PubMed ID: 26379405
    [Abstract] [Full Text] [Related]

  • 9. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S, Liu H, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb 25; 21(2):180-184. PubMed ID: 29492917
    [Abstract] [Full Text] [Related]

  • 10. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD, Tang P, Duan XF, Chen CG, Ma Z, Gao YY, Zhang H, Yu ZT.
    J Surg Oncol; 2013 Dec 25; 108(8):542-9. PubMed ID: 24018956
    [Abstract] [Full Text] [Related]

  • 11. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H, Chen C, Yue J, Ma M, Ma Z, Yu Z.
    Zhonghua Zhong Liu Za Zhi; 2014 Feb 25; 36(2):141-6. PubMed ID: 24796465
    [Abstract] [Full Text] [Related]

  • 12. Novel immunological and nutritional-based prognostic index for gastric cancer.
    Sun KY, Xu JB, Chen SL, Yuan YJ, Wu H, Peng JJ, Chen CQ, Guo P, Hao YT, He YL.
    World J Gastroenterol; 2015 May 21; 21(19):5961-71. PubMed ID: 26019461
    [Abstract] [Full Text] [Related]

  • 13. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
    Yuan D, Zhu K, Li K, Yan R, Jia Y, Dang C.
    J Surg Oncol; 2014 Sep 21; 110(3):333-40. PubMed ID: 24889121
    [Abstract] [Full Text] [Related]

  • 14. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K, Saeki H, Nakashima Y, Kamori T, Kawazoe T, Haruta Y, Fujimoto Y, Matsuoka H, Sasaki S, Jogo T, Hirose K, Hu Q, Tsuda Y, Kimura K, Ando K, Oki E, Ikeda T, Maehara Y.
    J Gastroenterol Hepatol; 2019 Feb 21; 34(2):355-363. PubMed ID: 30119141
    [Abstract] [Full Text] [Related]

  • 15. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
    Bösing NM, Heise JW, Goretzki PE, Sarbia M, Röher HD.
    Chirurg; 2004 Nov 21; 75(11):1088-97. PubMed ID: 15168031
    [Abstract] [Full Text] [Related]

  • 16. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Tu RH.
    Medicine (Baltimore); 2016 May 21; 95(21):e3473. PubMed ID: 27227913
    [Abstract] [Full Text] [Related]

  • 17. Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation.
    Liu F, Zhou R, Jiang F, Liu G, Li K, Zhu G.
    Ann Surg Oncol; 2019 May 21; 26(5):1292-1300. PubMed ID: 30805805
    [Abstract] [Full Text] [Related]

  • 18. Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
    Hirahara N, Tajima Y, Fujii Y, Kaji S, Yamamoto T, Hyakudomi R, Taniura T, Kawabata Y.
    BMC Cancer; 2018 Mar 13; 18(1):285. PubMed ID: 29534689
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis.
    Shi Y, Li L, Xiao H, Guo S, Wang G, Tao K, Dong J, Zong L.
    PLoS One; 2018 Mar 13; 13(9):e0203125. PubMed ID: 30256806
    [Abstract] [Full Text] [Related]

  • 20. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    Chen J, Xia YJ, Liu TY, Lai YH, Yu JS, Zhang TH, Ooi S, He YL.
    BMC Cancer; 2021 May 10; 21(1):532. PubMed ID: 33971833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.